NEUROTECH FUTURES

NEUROTECH FUTURES

Synchron's Thesis on Interventional Neurotechnology

As per Founder & CEO Dr. Tom Oxley

Naveen Rao's avatar
Naveen Rao
May 13, 2024
∙ Paid
2
1
Share

If you’re not following Dr. Tom Oxley on LinkedIn, you may have missed his 8 part post over the weekend, fresh on the heels of announcing his company Synchron’s expansion into Parkinson’s and Epileps…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Naveen Rao
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture